Canagliflozin is a C-glycosyl compound and an organofluorine compound that functions as a sodium-glucose transport protein subtype 2 inhibitor. It is used as a pharmaceutical raw material in the manufacturing of medications for the management of type II diabetes.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing Canagliflozin?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.
Canagliflozin hemihydrate
pharmaceutical raw material
Enoxacin sesquihydrate
pharmaceutical raw material
Flavin adenine dinucleotide disodium
pharmaceutical raw material
Bedaquiline
pharmaceutical raw material
Mifepristone
pharmaceutical raw material
[(2R,3R,4R,5S,6S)-3,4,5-triacetyloxy-6-[3-[[5-(4-fluorophenyl)thiophen-2-yl]methyl]-4-methylphenyl]oxan-2-yl]methyl acetate
pharmaceutical raw material
(1S)-1,5-Anhydro-1-C-[3-[[5-(4-fluorophenyl)-2-thienyl]methyl]-4-methylphenyl]-D-glucitol 2,3,4,6-tetrakis(2,2-dimethylpropanoate)
research compound
The international HS code for Canagliflozin (CAS 842133-18-0) is 2934.99.
2934.99
2934 99 90
Classification per the EU customs inventory ECICS (2026-07 snapshot, HS 2022). National tariff lines and product form can affect the final classification.
(2S,3R,4R,5S,6R)-2-[3-[[5-(4-fluorophenyl)thiophen-2-yl]methyl]-4-methylphenyl]-6-(hydroxymethyl)oxane-3,4,5-triol
XTNGUQKDFGDXSJ-ZXGKGEBGSA-N
CC1=C(C=C(C=C1)[C@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CO)O)O)O)CC3=CC=C(S3)C4=CC=C(C=C4)F
Sourcing Canagliflozin?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.